Intelligence

GBP pound sterling funding
#Biotech #Cancer Research Horizons #Cancer vaccine #Oncology #Start-ups #University of Oxford

Cancer vaccine developer secures £12.8m

Oxford University spin-out Infinitopes Precision Immunomics has completed a £12.8 ($16) million seed funding round led by Octopus Ventures. The round was heavily oversubscribed, also drawing in funds from Cancer Research Horizons, Cancer Research Institute, CRIS Cancer Foundation, Kindred Capital, Manta Ray, Martlet Capital, Meltwind Advisory,… Read More

#Business & Investment #News #Start-up Zone

#Cell and gene therapy #Drug discovery #In Focus Report

Cell and gene therapy: Global Innovation and Opportunity

Download this In Focus eReport to gain a full understanding of the current market for CGTs and the areas of greatest commercial potential for the future. The eReport includes: In-depth analysis of regional markets An overview of the likely challenges and opportunities The benefits of allogeneic CAR-T cell therapies The… Read More

#DDW eBooks #DDW In Focus eReports #Intelligence

Seed fund
#Biologics #Seed funding #Start-ups #University of Dundee

Dundee spin-out raises £4m to advance VLPs

Glen Clova Scientific has closed a £4 million (approximately $5 million) seed financing round, led by Norcliffe Capital together with investment from DSW Ventures, TRICAPITAL Angels and Scottish Enterprise. Glen Clova Scientific was founded in 2022 as a spin out from the University of Dundee to… Read More

#News #Start-up Zone

Monoclonal antibodies eBook cover
#Antibodies #Drug discovery #eBook #Monoclonal antibodies #Therapeutic Antibodies

Drug discovery and the impact of mAbs

This eBook, sponsored by Thermo Fisher Scientific, explores the impact of monoclonal antibodies (mAbs) on the treatment of cancer, autoimmune and infectious diseases, and inflammatory conditions, as well as the latest clinical research and where the innovation in mAb development might be in the future. Download this exclusive eBook to… Read More

#DDW eBooks #Intelligence

#Drug discovery #Therapeutic Antibodies

ebook: Drug discovery and the impact of mAbs

This eBook sponsored by Thermo Fisher Scientific explores the impact of monoclonal antibodies (mAbs) on the treatment of cancer, autoimmune and infectious diseases, and inflammatory conditions, as well as the latest clinical research and where the innovation in mAb development might be in the future. Download this exclusive eBook… Read More

#DDW eBooks

#Antibodies #Artificial intelligence (AI) #Biologics #Investment #Seed funding #Start-ups

AI drug discovery company Xaira launches with $1b investment

Xaira Therapeutics, a joint incubation by ARCH Venture Partners and Foresite Labs, has launched with more than $1 billion of committed capital from lead investors. Xaira is building a platform for drug discovery and development that it hopes will advance multiple drug programmes and unlock biological… Read More

#News #Start-up Zone #Trending News

University of Birmingham
#Academic #Drug discovery #Funding #Investment #Start-ups #University of Birmingham

Birmingham, UK, Drug Discovery Hub created

The Birmingham Drug Discovery Hub (BDDH) has been set up to help University of Birmingham researchers to overcome the ‘valley of death’, where projects fail due to the funding gap between original research and commercial investment. The hub has attracted more than £4 ($4.9) million in… Read More

#News #Start-up Zone

#Bios Health Group #Biotech #Biotech hubs #Collaboration #Life science #Start-ups

Bios launches biotech hub to support life science progress

Bios Health Group has launched the Bios Innovation Circle – a new venture studio and strategic hub, designed to support biotechnology and life science companies towards growing success. The Bios Innovation Circle is a venture studio and strategic hub designed to catalyse the growth of start-ups,… Read More

#News #Start-up Zone

#Drug discovery

App Note: Innovative strategies for maximising binding capacity

As the demand for mRNA-based therapies surges, the efficiency of the production process becomes paramount. Binding conditions in affinity chromatography need to be optimised, to keep up with the increasing efficiency of IVT reactions, and to deliver high yields and purities. In this application note, we demonstrate… Read More

#App Notes

#Financing #Neurology #Neurosterix #Schizophrenia #Start-ups

$63m for allosteric modulators for neurological disorders

Neurosterix has launched with a $63 million Series A financing led by Perceptive Xontogeny Venture Fund II, with participation from Perceptive Life Sciences Fund and Acorn Bioventures. The company will acquire Addex’s allosteric modulator discovery technology platform. The platform has a track record of identifying highly… Read More

#Editor's Choice #News #Start-up Zone

#Bispecific therapeutics #Drug discovery #Human disease models #Mouse models #Preclinical development #Preclinical investigations #Toxicology

Streamline preclinical drug discovery: PBMC-humanised mouse models

Discover a clinically predictive and reproducible platform developed by The Jackson Laboratory for simultaneous efficacy and safety assessment. This platform identifies patient-therapy combinations at risk of developing severe inflammatory syndrome, a potentially fatal complication. Optimise the safety profiles of your immunomodulatory therapeutics before first-in-human trials by leveraging this platform. In… Read More

#Resources

#Cancer research #Drug discovery #eBook #Oncology

Breakthroughs in oncology research and drug discovery

This 24-page eBook sponsored by Sino Biological explores the latest innovations in cancer therapeutics and where we can expect the greatest breakthroughs in the future. Download this exclusive eBook to learn more about: The opportunities and advances in cancer research Why liquid biopsies are important in precision medicine trials for… Read More

#DDW eBooks #Intelligence

#Cancer research #Drug discovery #In Focus Report #Oncology

Oncology Research: Where are the breakthroughs & innovation?

Download this exclusive DDW eReport to learn more about: Oncology drug discovery and development: A market overview The technologies and therapeutic approaches that will drive the future of cancer drug discovery Oncology, drug discovery and the potential of organoids The research driving advancements in oncology and recent approvals in the sector… Read More

#DDW eBooks #DDW In Focus eReports #Intelligence